Positive impact of tacrolimus-based immunosuppression after lung transplantation – an analysis of potential risk factors for long-term survival

P. Huppmann, C. Neurohr, B. Samweber, R. Baumgartner, M. El Nounou, G. Zimmermann, F. Ihle, H. Leuchte, P. Ueberfuhr, R. Hatz, L. Frey, J. Behr (Munich, Germany)

Source: Annual Congress 2007 - New insights into clinical lung transplantation
Session: New insights into clinical lung transplantation
Session type: Electronic Poster Discussion
Number: 331
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Huppmann, C. Neurohr, B. Samweber, R. Baumgartner, M. El Nounou, G. Zimmermann, F. Ihle, H. Leuchte, P. Ueberfuhr, R. Hatz, L. Frey, J. Behr (Munich, Germany). Positive impact of tacrolimus-based immunosuppression after lung transplantation – an analysis of potential risk factors for long-term survival. Eur Respir J 2007; 30: Suppl. 51, 331

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The impact of smoking relapse on the outcome after lung transplantation
Source: Annual Congress 2012 - Optimising outcomes after lung transplantation
Year: 2012

How to improve long-term outcomes following lung transplantation
Source: International Congress 2019 – Lung transplantation in 2019: where are we?
Year: 2019


Airway complications after lung transplantation: risk factors and survival
Source: Virtual Congress 2020 – Clinical management of lung transplant recipients
Year: 2020


Potential risk factors for poor outcomes post-lung transplant for cystic fibrosis
Source: International Congress 2019 – Lung transplantation: from basic science to clinical outcomes
Year: 2019

Predictors of survival of patients waiting for lung transplantation
Source: Eur Respir J 2004; 24: Suppl. 48, 178s
Year: 2004

Long-term follow-up after lung transplantation – impact of A1-rejection?
Source: Eur Respir J 2006; 28: Suppl. 50, 724s
Year: 2006

Analysis of factors affecting pretransplant pulmonary function tests and impact on overall survival after allogenic stem cell transplantation
Source: International Congress 2015 – Outcomes of lung transplantation
Year: 2015

The use of mTOR inhibitors is associated with improved survival in lung transplant recipients
Source: Virtual Congress 2020 – Treatments and biomarkers for lung allograft function and outcome
Year: 2020

A virtual crossmatch-based strategy for perioperative desensitisation in lung transplant recipients with pre-formed donor-specific antibodies: 3-year outcome
Source: Eur Respir J, 58 (5) 2004090; 10.1183/13993003.04090-2020
Year: 2021



Long-term management, functional outcome and results
Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=179
Year: 2003

Aspergillus infections in lung transplant recipients. Risk factors and outcome
Source: Eur Respir J 2004; 24: Suppl. 48, 178s
Year: 2004

The influence of different immunosuppressive regimen on non-mnestic cognitive functions in patients after lung transplantation
Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues
Year: 2014

Current outcome after lung transplantation
Source: Annual Congress 2012 - Lung transplantation in 2012: where are we?
Year: 2012


Immunophenotype and gene signature of long-term survivors with normal allograft function after lung transplantation
Source: International Congress 2019 – Lung transplantation: from basic science to clinical outcomes
Year: 2019

Prevalence of pre-transplant anti-HLA antibodies and their impact on outcomes in lung transplant recipients
Source: International Congress 2016 – Long-term outcomes of lung transplantation
Year: 2016

Smoking resumption after lung transplantation: standardised screening and importance for long-term outcome
Source: Eur Respir J 2014; 43: 300-303
Year: 2004


Tuberculosis infection in renal transplant recipients and evaluation of risk factors.>
Source: Virtual Congress 2020 – Tuberculosis and society
Year: 2020


Analysis of the nasal microbiome in long-term survivors after lung transplantation with a good allograft function
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019

The effect of comorbidities on long-term survival in COPD
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018

Evaluation of the biological effects of atorvastatin in lung transplant recipients
Source: Annual Congress 2007 - New insights into clinical lung transplantation
Year: 2007